Biotech Day in Review: Hopeful Results from HIV Conference


Biotech Day in Review: Hopeful Results from HIV Conference

Centient Biotech Investor submits: At the HIV Conference held in Los Angeles last week, several companies reported good results from new approaches to HIV/AIDS treatments.Pfizer (PFE) reported that maraviroc produced an undetectable level of virus in twice as many patients as an optimized regimen. Maraviroc was given as an adjunct to the optimized

You might be interested in these entries too:

Biotech Week in Review: Onyx Is Star of the Week

Centient Biotech Investor submits: A very minor advance was the best that biotech could do last week. The Centient Biotech 200™ rose just 4 points, which equates...

Disclosure of HIV test results violated privacy

TALLAHASSEE, Fla.?An employer and a medical laboratory can be held liable for disclosing HIV test results for a correctional facility nurse, Florida?s Supreme Court ruled Thursday in a 4-3 decision....

Responses to 'Biotech Day in Review: Hopeful Results from HIV Conference'


  1. No Comments

Leave a Reply





eXTReMe Tracker